During last month’s visit my Onc said options were limited for treating the new growth on my liver. My choices were the study drug TK1258 or Vinorelbine (Naveltine). Because I don’t qualify for the study drug ... Vinorelbine is it.
Back then I didn’t have the courage to ask the Onc what he meant by… limited options.
Today I asked the question. How many options do I have left? He said if Vinorelbine fails, I will be put on compassionate care.
I asked if I could try DCA and he said he would look into it.
No comments:
Post a Comment